Jean F Holloway Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 4 hours ago
Jean F Holloway has an estimated net worth of at least $12.7 million*, as of March 11, 2026. They own 185,095 shares of AORT stock. They have sold 185,756 shares of AORT stock since 2021, for an estimated $6.2 million.
Jean F Holloway $AORT SEC Form 4 Insider Trading
Jean F Holloway has filed a total of 41 insider trades in $AORT since 2021. Their most recent trade was a sale of 3,843 shares, made on Mar 03, 2026. Their largest trade was a sale of 21,229 shares, made on Jan 02, 2024. We estimate that they now own 185,095 shares of $AORT, worth an estimated $6.5 million.
Insider Trading at $AORT
There have been a total of 216 insider trades reported at $AORT since 2021, with 0 shares purchased and 1.3 million shares sold. The most active insider traders in $AORT stock have been Jean F Holloway, Marshall S. Stanton, and James P Mackin. The most recent trade was a sale of 901 shares reported by Amy Horton (VP, Chief Accounting Officer), made on Mar 03, 2026.
History of Insider Stock Trades by Jean F Holloway
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
AORT
|
Sale | 3,843 | Mar 03, 2026 | March 4, 2026, 7:53 p.m. |
AORT
|
Sale | 8,962 | Mar 04, 2026 | March 4, 2026, 7:53 p.m. |
AORT
|
Sale | 2,183 | Mar 02, 2026 | March 3, 2026, 4 p.m. |
AORT
|
Sale | 3,079 | Feb 23, 2026 | Feb. 25, 2026, 6:35 p.m. |
AORT
|
Sale | 1,668 | Feb 24, 2026 | Feb. 25, 2026, 6:35 p.m. |
AORT
|
Sale | 5,267 | Dec 03, 2025 | Dec. 4, 2025, 9:52 p.m. |
AORT
|
Sale | 2,048 | Dec 03, 2025 | Dec. 4, 2025, 9:52 p.m. |
AORT
|
Sale | 6,394 | Nov 17, 2025 | Nov. 18, 2025, 2:11 p.m. |
AORT
|
Sale | 6,393 | Nov 14, 2025 | Nov. 18, 2025, 2:11 p.m. |
AORT
|
Sale | 5,761 | Nov 13, 2025 | Nov. 14, 2025, 1:08 p.m. |
AORT
|
Sale | 2,960 | Nov 10, 2025 | Nov. 12, 2025, 9:12 p.m. |
AORT
|
Sale | 10,000 | Nov 11, 2025 | Nov. 12, 2025, 9:12 p.m. |
AORT
|
Sale | 10,000 | Aug 25, 2025 | Aug. 26, 2025, 10:39 a.m. |
AORT
|
Sale | 6,381 | Aug 12, 2025 | Aug. 14, 2025, 9:58 a.m. |
AORT
|
Sale | 16,975 | Aug 12, 2025 | Aug. 14, 2025, 9:58 a.m. |
AORT
|
Sale | 8,748 | May 27, 2025 | May 27, 2025, 5:29 p.m. |
AORT
|
Sale | 9,926 | May 21, 2025 | May 21, 2025, 2:43 p.m. |
AORT
|
Sale | 18,020 | Mar 11, 2025 | March 12, 2025, 3:41 p.m. |
AORT
|
Sale | 2,124 | Mar 06, 2025 | March 10, 2025, 5 p.m. |
AORT
|
Sale | 472 | Mar 05, 2025 | March 6, 2025, 9:53 a.m. |
AORT
|
Sale | 1,650 | Feb 24, 2025 | Feb. 26, 2025, 2:57 p.m. |
AORT
|
Sale | 2,385 | Feb 24, 2025 | Feb. 26, 2025, 2:57 p.m. |
AORT
|
Sale | 490 | Feb 24, 2025 | Feb. 26, 2025, 2:57 p.m. |
AORT
|
Sale | 810 | Feb 24, 2025 | Feb. 26, 2025, 2:57 p.m. |
AORT
|
Sale | 4,035 | Dec 11, 2024 | Dec. 12, 2024, 5:11 p.m. |
AORT
|
Sale | 4,035 | Dec 11, 2024 | Dec. 12, 2024, 5:11 p.m. |
AORT
|
Sale | 3,167 | Aug 26, 2024 | Aug. 27, 2024, 4:47 p.m. |
AORT
|
Sale | 2,383 | Aug 15, 2024 | Aug. 16, 2024, 11:38 a.m. |
AORT
|
Sale | 1,250 | May 10, 2024 | May 13, 2024, 6:05 p.m. |
AORT
|
Sale | 979 | May 09, 2024 | May 10, 2024, 5:12 p.m. |
AORT
|
Sale | 2,380 | Mar 05, 2024 | March 7, 2024, 7:16 p.m. |
AORT
|
Sale | 485 | Feb 27, 2024 | Feb. 29, 2024, 6:34 p.m. |
AORT
|
Sale | 1,314 | Feb 26, 2024 | Feb. 28, 2024, 6:18 p.m. |
AORT
|
Sale | 1,566 | Feb 26, 2024 | Feb. 28, 2024, 6:18 p.m. |
AORT
|
Sale | 464 | Feb 20, 2024 | Feb. 22, 2024, 6:37 p.m. |
AORT
|
Sale | 1,192 | Feb 20, 2024 | Feb. 22, 2024, 6:37 p.m. |
AORT
|
Sale | 1,871 | Feb 20, 2024 | Feb. 22, 2024, 6:37 p.m. |
AORT
|
Sale | 21,229 | Jan 02, 2024 | Jan. 4, 2024, 5:25 p.m. |
AORT
|
Sale | 907 | Mar 02, 2023 | March 3, 2023, 6:48 p.m. |
AORT
|
Sale | 966 | Feb 27, 2023 | March 1, 2023, 7:46 p.m. |
AORT
|
Sale | 994 | Feb 27, 2023 | March 1, 2023, 7:46 p.m. |
$AORT Executives and Stock Owners with Insider Trades
-
Jean F Holloway, SVP, General Counsel
-
Marshall S. Stanton, SVP, Clinical & MD Affair
-
James P Mackin, President & CEO
-
Amy Horton, VP, Chief Accounting Officer
-
John E Davis, Chief Commercial Officer
-
Matthew A Getz, VP, Human Resources
-
Andrew M Green, VP Regulatory
-
Dennis B Maier, SVP, Operations
-
Rochelle L. Maney, VP, Quality
-
David Ashley Lee, Executive VP, COO & CFO
-
John E Davis, Senior VP, Global Sales
-
Lance A Berry, EVP, COO, CFO & Treasurer
-
Florian Tyrs, VP, Global Operations
-
Lance A Berry, Executive VP, CFO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.